PL BioScience GmbH

📍 Aachen, Germany🗓 Founded 2015👥 33 employees💰 Last funded Jun 2023
Biotechnology🌐 pl-bioscience.com
Website LinkedIn
At PL BioScience, we are experts in Human Platelet Lysate. Our mission is to support advances in cellular research and therapy with our revolutionary technology: the ELAREM™ HPL platform. Its xeno-free origin, combined with its naturally rich growth factor content not only supports cell growth and expansion, but also enables various applications. And with Research- and GMP-grade products available, ELAREM™ covers all steps of cell expansion in academic research, pre-clinical research and cellular therapy. This ensures seamless transitions in regenerative medicine – from blood bank, to bench, to bedside. Our story goes back to 2015, with the mission to deliver xeno-free cell culture supplements. Today, we continue to change the possibilities of cell expansion; researchers switch from Fetal Bovine Serum to our animal suffering-free products. Our signature innovation continues to guide us, as we work to support all stages of research, with premium quality HPL. Join us today in Innovating Cell Culture!
5
Total investors
0
Early stage
3
Mid stage
2
Late stage
2015
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Germany
4
Netherlands
1
Investor activity2018–2023 · investors recorded per year
20181202022022120231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in PL BioScience GmbH?
PL BioScience GmbH has 5 investors on record on gritt.io, 3 mid-stage and 2 late-stage investors.
When did PL BioScience GmbH last raise funding?
The most recent investment in PL BioScience GmbH recorded on gritt.io was in June 2023.
When was PL BioScience GmbH founded?
PL BioScience GmbH was founded in 2015.
What industry is PL BioScience GmbH in?
PL BioScience GmbH operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is PL BioScience GmbH based?
PL BioScience GmbH is headquartered in Aachen, Germany.